Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

The Impact of Non-Clinical Factors in Clinical Trial Enrollments of Patients with Hematologic Malignancies

Jamile M. Shammo, Anne Timmermann, Deborah A. Katz, Agne Paner, Seo-Hyun Kim, Irene dehghan-Paz, Melissa L. Larson, Parameswaran Venugopal, Celalettin Ustun, Ankur Varma, Sunita Nathan

Blood (2021) 138 (Supplement 1): 1914.

https://doi.org/10.1182/blood-2021-148135

Published: 2021

Journal Articles

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies

Elizabeth Behrens, MD, Anne Timmermann, Alexander Yerkan, Deborah A. Katz, MD, Agne Paner, MD, Melissa C. Larson, MD, Seo-Hyun Kim, MD, Shivi Jain, MDMBBS, Sefer Gezer, MD, Parameswaran Venugopal, MD, Irene Dehghan-Paz, Yoona Rhee, Celalettin Ustun, MD, Ankur Varma, Jamile M. Shammo, MD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141063

Published: 2020

Journal Articles

Open-Label, Phase 2 Study of Blinatumomab after First-Line Rituximab-Chemotherapy in Adults with Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma

Deborah A. Katz, MD, Michael P. Chu, Kevin A. David, MD, Catherine Thieblemont, MD PhD, Nicholas J. Morley, Sharif S. Khan, Yuqi Chen, James Kalabus, Joan Morris, Abraham Anderson, Ariel A. Avilion, Eva González-Barca, MD PhD

Blood (2019) 134 (Supplement_1): 4077.

https://doi.org/10.1182/blood-2019-121708

Published: 2019

Journal Articles

A Phase 2a Open-Label Study to Investigate Safety and Tolerability (including the MTD), Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of MT-3724 in Combination with Gemcitabine and Oxaliplatin in Subjects with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Christine Burnett, Thomas Strack, MD, Tara Lehner, MS, PMP, Jack P Higgins, PhD, Deborah A. Katz, MD, Matthew S. McKinney, MD

Blood (2019) 134 (Supplement_1): 5322.

https://doi.org/10.1182/blood-2019-124890

Published: 2019

Journal Articles

Successful Early Outcome with Low-Dose (400 cGY) Total Body Irradiation in Combination with Busulfan and Fludarabine Myeloablative Conditioning Followed By Matched Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Non-Remission Acute Myelogeneous Leukemia with Diffuse Extramedullary Disease in Multiple Sites

Gorgun Akpek, MD MHS, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Deborah A. Katz, MD, Ashley Echeverria, PA-C, Lindsay Hodges, RN, APN, Aidnag Z. Diaz, MD MPH, Ross Allen Abrams, MD

Blood (2016) 128 (22): 5769.

https://doi.org/10.1182/blood.V128.22.5769.5769

Published: 2016

Journal Articles

Incidence and Characteristics of Therapy-Related Myeloid Neoplasms in Patients with Non-Hodgkins Lymphoma Treated with Radioimmunotherapy

Salman Waheed, MD, Iva Ferreira, MD, Deborah A. Katz, MD, Reem Karmali, MD, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD, Jamile M. Shammo, MD

Blood (2012) 120 (21): 4924.

https://doi.org/10.1182/blood.V120.21.4924.4924

Published: 2012

Journal Articles

New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group report of 343 cases

Nancy R. Schneider, Andrew J. Carroll, Jonathan J. Shuster, D. Jeanette Pullen, Michael P. Link, Michael J. Borowitz, Bruce M. Camitta, Julie A. Katz, Michael D. Amylon

Blood (2000) 96 (7): 2543–2549.

https://doi.org/10.1182/blood.V96.7.2543

Published: 2000

Journal Articles

Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection

A Marandin, A Katz, E Oksenhendler, M Tulliez, F Picard, W Vainchenker, F Louache

Blood (1996) 88 (12): 4568–4578.

https://doi.org/10.1182/blood.V88.12.4568.bloodjournal88124568

Published: 1996

Journal Articles

Phenotype and function of human hematopoietic cells engrafting immune- deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells

F Pflumio, B Izac, A Katz, LD Shultz, W Vainchenker, L Coulombel

Blood (1996) 88 (10): 3731–3740.

https://doi.org/10.1182/blood.V88.10.3731.bloodjournal88103731

Published: 1996

Journal Articles

Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow

N Debili, L Coulombel, L Croisille, A Katz, J Guichard, J Breton-Gorius, W Vainchenker

Blood (1996) 88 (4): 1284–1296.

https://doi.org/10.1182/blood.V88.4.1284.bloodjournal8841284

Published: 1996

Journal Articles

Characterization of hematopoietic progenitors from human yolk sacs and embryos

A Huyhn, M Dommergues, B Izac, L Croisille, A Katz, W Vainchenker, L Coulombel

Blood (1995) 86 (12): 4474–4485.

https://doi.org/10.1182/blood.V86.12.4474.bloodjournal86124474

Published: 1995

Journal Articles

The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors

N Debili, F Wendling, A Katz, J Guichard, J Breton-Gorius, P Hunt, W Vainchenker

Blood (1995) 86 (7): 2516–2525.

https://doi.org/10.1182/blood.V86.7.2516.2516

Published: 1995

Journal Articles

Hydrocortisone differentially affects the ability of murine stromal cells and human marrow-derived adherent cells to promote the differentiation of CD34++/CD38- long-term culture-initiating cells

L Croisille, I Auffray, A Katz, B Izac, W Vainchenker, L Coulombel

Blood (1994) 84 (12): 4116–4124.

https://doi.org/10.1182/blood.V84.12.4116.bloodjournal84124116

Published: 1994

Journal Articles

Growth and differentiation of the human megakaryoblastic cell line (ELF- 153): a model for early stages of megakaryocytopoiesis

MA Mouthon, M Freund, M Titeux, A Katz, J Guichard, J Breton-Gorius, W Vainchenker

Blood (1994) 84 (4): 1085–1097.

https://doi.org/10.1182/blood.V84.4.1085.1085

Published: 1994

Journal Articles

Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells

N Debili, JM Masse, A Katz, J Guichard, J Breton-Gorius, W Vainchenker

Blood (1993) 82 (1): 84–95.

https://doi.org/10.1182/blood.V82.1.84.bloodjournal82184

Published: 1993

Journal Articles

A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays

C Issaad, L Croisille, A Katz, W Vainchenker, L Coulombel

Blood (1993) 81 (11): 2916–2924.

https://doi.org/10.1182/blood.V81.11.2916.2916

Published: 1993

Journal Articles

Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation

N Debili, C Issaad, JM Masse, J Guichard, A Katz, J Breton-Gorius, W Vainchenker

Blood (1992) 80 (12): 3022–3035.

https://doi.org/10.1182/blood.V80.12.3022.3022

Published: 1992

Journal Articles

In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes

N Debili, E Hegyi, S Navarro, A Katz, MA Mouthon, J Breton-Gorius, W Vainchenker

Blood (1991) 77 (11): 2326–2338.

https://doi.org/10.1182/blood.V77.11.2326.2326

Published: 1991

Journal Articles

In vitro inhibition of normal human hematopoiesis by marrow CD3+, CD8+, HLA-DR+, HNK1+ lymphocytes

G Vinci, JP Vernant, M Nakazawa, M Zohair, A Katz, A Henri, H Rochant, J Breton- Gorius, W Vainchenker

Blood (1988) 72 (5): 1616–1621.

https://doi.org/10.1182/blood.V72.5.1616.1616

Published: 1988

Journal Articles

Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment

JP Marolleau, T Henni, P Gaulard, JP Le Couedic, MF Gourdin, M Divine, A Katz, M Tulliez, M Goossens, F Reyes

Blood (1988) 72 (2): 655–660.

https://doi.org/10.1182/blood.V72.2.655.655

Published: 1988

NARROW

The Impact of Non-Clinical Factors in Clinical Trial Enrollments of Patients with Hematologic Malignancies

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies

Open-Label, Phase 2 Study of Blinatumomab after First-Line Rituximab-Chemotherapy in Adults with Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma

A Phase 2a Open-Label Study to Investigate Safety and Tolerability (including the MTD), Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of MT-3724 in Combination with Gemcitabine and Oxaliplatin in Subjects with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Incidence and Characteristics of Therapy-Related Myeloid Neoplasms in Patients with Non-Hodgkins Lymphoma Treated with Radioimmunotherapy

New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group report of 343 cases

Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection

Phenotype and function of human hematopoietic cells engrafting immune- deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells

Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow

Characterization of hematopoietic progenitors from human yolk sacs and embryos

The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors

Hydrocortisone differentially affects the ability of murine stromal cells and human marrow-derived adherent cells to promote the differentiation of CD34++/CD38- long-term culture-initiating cells

Growth and differentiation of the human megakaryoblastic cell line (ELF- 153): a model for early stages of megakaryocytopoiesis

Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells

A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays

Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation

In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes

In vitro inhibition of normal human hematopoiesis by marrow CD3+, CD8+, HLA-DR+, HNK1+ lymphocytes

Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only